Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Yes, it would not work to their benefit. Once they get the pipeline going that they should have done years ago they would be ready with fundamentals to uplist. Elite has been a show me stock for years. It has consistently shown that it’s in a rut, but hopefully it’s starting to dig out, but with a plastic spoon.

We spent a ton on ANDAs in the past that we just sold off for pennies on the dollar. Let’s see if Elite can prove that they can both invest and execute for heavy top line growth. Adderall ANDAs have been less than stellar after CEO hyped that they expect 10% of the market of a billion dollar market. Adderall ER is struggling to get 1% of the market.

Execution speaks louder than words, which is why this stock is stuck. Even though the company has finally reached CFP, management has to rebuild trust with investors. Lack of communication doesn’t help. Management should never surprise investors and this company is always full of surprises. I’ll let others determine whether those surprises have been good or bad surprises. Just look at stock price. Hint: Stock price is lower than when CEO started 8 years ago and dilution has tripled.